Related Experiment Video

Updated: Nov 10, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

120

microRNAs as Novel Therapeutics in Cancer

Giulia Romano1, Mario Acunzo1, Patrick Nana-Sinkam1

  • 1Department of Internal Medicine, Division of Pulmonary Diseases and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.

Cancers
|April 3, 2021
PubMed

Insights

MicroRNAs (miRNAs) are key gene regulators in cancer, but their clinical use is limited by delivery challenges. Advances in novel formulations and targeted delivery vectors are paving the way for effective miRNA cancer therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are established regulators of gene expression across biological pathways.
  • miRNAs play critical roles in cancer hallmarks like apoptosis, proliferation, migration, and invasion.
  • Deregulation of miRNAs is implicated in numerous cancers, highlighting their therapeutic potential.

Purpose of the Study:

  • To review the progress and challenges in translating miRNA research into clinical cancer therapy.
  • To discuss advancements in miRNA delivery vehicles and targeted therapeutic strategies.
  • To highlight the potential of miRNA-based drugs in cancer treatment.

Main Methods:

  • Review of recent literature on miRNA function in cancer.
  • Analysis of novel formulations and vectors for oligonucleotide delivery.
  • Examination of targeted delivery strategies for miRNA therapeutics.
  • Overview of current clinical trials involving miRNA drugs.

Main Results:

  • Significant progress has been made in understanding miRNA roles in cancer.
  • Novel formulations and vectors have improved miRNA stability and therapeutic effectiveness.
  • Targeted delivery moieties enhance specificity in tumor cells.
  • Early clinical trials show promising results for miRNA-based cancer drugs.

Conclusions:

  • Despite challenges in safe and efficient delivery, miRNA-based cancer therapies show great potential.
  • Advancements in delivery technologies are overcoming major obstacles to clinical application.
  • Several miRNA drugs are progressing through clinical trials, indicating a promising future for this therapeutic modality.
Keywords:
cancersmall non-coding RNAtherapy

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

593
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
620